Investigating the nitric oxide pathway stimulated by rosuvastatin on the pathological effects of renal ischemia–reperfusion in rats
Journal of Pharmacy and Pharmacology · 2026
DOI: 10.1093/jpp/rgaf097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Zahra Haghighatian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Medicine, Lorestan University of Medical Science, Khorramabad, Iran. Hauptthemen laut MEDLINE: Rosuvastatin Calcium, Reperfusion Injury, Nitric Oxide, Kidney. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Lorestan University of Medical Sciences.
Abstract (Originalsprache)
Introduction
Renal ischemia–reperfusion (RIR) induces inflammation, oxidative stress, and impaired renal function, partly through reduced nitric oxide (NO) availability. Rosuvastatin enhances NO production and has reported organ-protective effects. This study examined whether rosuvastatin confers renoprotection in RIR through NO-dependent mechanisms. Materials and methods Five groups of rats (n = 6) were used: control, RIR, RIR + rosuvastatin, RIR + rosuvastatin + L-NAME (NG-Nitro-L-arginine methyl ester), and RIR + rosuvastatin + L-arginine. Drugs were administered once daily from 3 days before ischemia until 24 h after reperfusion. Twenty-four-hour urine, blood, and kidney tissues were collected for analysis. Statistical tests were performed with Prism software.
Results
Rosuvastatin significantly reduced serum urea and creatinine levels versus RIR alone. Glomerular filtration rate increased, though proteinuria remained unchanged. Inflammatory cytokines and oxidative stress decreased markedly, while tissue NO levels rose in the rosuvastatin group. L-NAME co-treatment diminished these effects, whereas L-arginine enhanced them, indicating NO involvement.
Conclusion
Rosuvastatin ameliorated renal injury in RIR, likely through activation of NO signaling. These findings suggest a potential therapeutic role for rosuvastatin in ischemic renal injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Medicine, Lorestan University of Medical Science, Khorramabad, Iran.
- Department of Biostatistics and Epidemiology, School of Health and Nutrition, Lorestan University of Medical Sciences, Khorramabad, Iran.
- Department of Nephrology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
- Department of Pharmacology and Toxicology, School of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran.
ORCID-Profile: Amin Hasanvand
Förderung
- Lorestan University of Medical Sciences
Zitieren
APA
Haghighatian, Z., Goodarzi, E., Hadian, B., & Hasanvand, A. (2026). Investigating the nitric oxide pathway stimulated by rosuvastatin on the pathological effects of renal ischemia–reperfusion in rats. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf097
Vancouver
Haghighatian Z, Goodarzi E, Hadian B, Hasanvand A. Investigating the nitric oxide pathway stimulated by rosuvastatin on the pathological effects of renal ischemia–reperfusion in rats. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgaf097
BibTeX
@article{Haghighatian2026,
author = {Haghighatian, Zahra and Goodarzi, Elham and Hadian, Babak and Hasanvand, Amin},
title = {Investigating the nitric oxide pathway stimulated by rosuvastatin on the pathological effects of renal ischemia–reperfusion in rats},
journal = {Journal of Pharmacy and Pharmacology},
year = {2026},
doi = {10.1093/jpp/rgaf097}
}
EUVIMED